Programming Strategy of VFS for Gait Impairments in PD

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05905198
Collaborator
(none)
30
1
2
9.3
3.2

Study Details

Study Description

Brief Summary

Variable Frequency Stimulation(VFS) is a stimulation pattern applied in Deep Brain Stimulation(DBS) therapy for Parkinson's disease(PD). Peking Union Medical College Hospital was the first centre conducting research on VFS. The studies in the past have resembled conclusion that VFS provides improvement not only in the major symptoms such as tremor and rigidity, but also in gait and balance disorder. However, the best programming strategy of VFS has not met agreement. The random-controlled double blinded crossover study is designed for participants who underwent DBS surgery in bilateral subthalamic nucleus for parkinson's disease. The investigators study several strategies on programming and observe the improvement of symptom to look for the best one. A 4-month follow-up is designed to observe a relatively long-term effectiveness of VFS. The study intends to gather more clinical evidence to guide further studies on VFS application.

Condition or Disease Intervention/Treatment Phase
  • Device: Programming
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Programming Strategy of Variable Frequency Stimulation for Gait Impairments in Parkinson's Disease
Actual Study Start Date :
May 24, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: HFS-VFS

This arm will experience HFS first during the crossover, and then VFS.

Device: Programming
programming the implanted DBS device to adjust the parameter and switch stimulation mode between Variable-Frequency settings and High-Frequency settings.

Experimental: VFS-HFS

This arm will experience VFS first during the crossover, and then HFS.

Device: Programming
programming the implanted DBS device to adjust the parameter and switch stimulation mode between Variable-Frequency settings and High-Frequency settings.

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline 5m-Timed Up and Go test Time Result at 2 months. [Baseline, 2 months]

    Conduct a TUG test with 5m range setting and measure the time cost

  2. Change from Baseline 5m-Timed Up and Go test Time Result at 4 months. [Baseline, 4 months]

    Conduct a TUG test with 5m range setting and measure the time cost

Secondary Outcome Measures

  1. Change from Baseline 5m-Timed Up and Go test Step Frequency at 2 months. [Baseline, 2 months]

    Conduct a TUG test with 5m range setting and measure the step movement and calculate the step frequency

  2. Change from Baseline 5m-Timed Up and Go test Step Frequency at 4 months. [Baseline, 4 months]

    Conduct a TUG test with 5m range setting and measure the step movement and calculate the step frequency

  3. Change from Baseline 5m-Timed Up and Go test Length at 2 months. [Baseline, 2 months]

    Conduct a TUG test with 5m range setting and measure the length of each step

  4. Change from Baseline 5m-Timed Up and Go test Step Length at 4 months. [Baseline, 4 months]

    Conduct a TUG test with 5m range setting and measure the length of each step

  5. Change from Baseline 5m-Timed Up and Go test Step Variation Coefficient at 2 months. [Baseline, 2 months]

    Conduct a TUG test with 5m range setting and use the length of each step to calculate the difference coefficient

  6. Change from Baseline 5m-Timed Up and Go test Step Variation Coefficient at 4 months. [Baseline, 4 months]

    Conduct a TUG test with 5m range setting and use the length of each step to calculate the difference coefficient

  7. Change from Baseline Movement Disorder Society Unified Parkinson's Disease Rating Scale part III score at 2 months. [Baseline, 2 months]

    Conduct a Movement Disorder Society Unified Parkinson's Disease Rating Scale survey and record the score. Higher MDS UPDRS III score represents worse movement disorder symptoms.

  8. Change from Baseline Movement Disorder Society Unified Parkinson's Disease Rating Scale part III score at 4 months. [Baseline, 4 months]

    Conduct a Movement Disorder Society Unified Parkinson's Disease Rating Scale survey and record the score. Higher MDS UPDRS III score represents worse movement disorder symptoms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Idiopathic Parkinson's disease (according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease);

  • 18-75 years of age;

  • Hoehn & Yahr ≤ 3 (in best OFF-medication condition);

  • Implanted bilateral subthalamic nucleus DBS for over 1 year;

  • gait Impairments in OFF-medication condition;

  • High Frequency Stimulation provides significant improvement;

  • in OFF-medication On-stimulation condition, capable of walking ≥ 10m.

Exclusion Criteria:
  • mental disorder or dementia;

  • Pregnant women, lactating mothers or women who are unable to take effective measures to prevent pregnancy;

  • With other diseases that can affect walking distance, such as joint diseases of the lower body, spinal diseases, neuropathy, or serious heart or lung diseases;

  • In severe health condition, such as diseases associated with heart or liver;

  • Epilepsy;

  • Lead off target;

  • Unable to willingly sign Written informed Consent;

  • Disagree or unable to cooperate with follow-up sessions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking Union Medical College Hospital Beijing China 100730

Sponsors and Collaborators

  • Peking Union Medical College Hospital

Investigators

  • Principal Investigator: Yi Guo, M.D., Peking Union Medical College Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT05905198
Other Study ID Numbers:
  • K3438
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Peking Union Medical College Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2023